Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
filingDate |
1987-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1994-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c01ae7e06bebdb72606bbbe95b7b76e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef85bb6e5b80b0fde61a4b171090ec76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e692f5ed622be4459b545c35d92bce34 |
publicationDate |
1994-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0248583-B1 |
titleOfInvention |
Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
abstract |
Human basal cell carcinoma is successfully treated by intralesional administration of recombinant human alpha interferon, especially interferon alfa-2b. The preparation of suitable pharmaceutical compositions is disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4019037-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018178215-A1 |
priorityDate |
1986-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |